BioWorld-International-2006-01-18
MorphoSys Boosts Antibody Work With $35M Acquisition
MorphoSys Boosts Antibody Work With $35M Acquisition
Expecting to triple the revenues from its research antibody division, MorphoSys AG is buying privately held Serotec Ltd. in a cash and stock deal valued at 29.3 million (US$35.3 million). (BioWorld International)

